Julie Bruneau

13.3k total citations · 4 hit papers
211 papers, 8.1k citations indexed

About

Julie Bruneau is a scholar working on Epidemiology, Hepatology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Julie Bruneau has authored 211 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 156 papers in Epidemiology, 85 papers in Hepatology and 59 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Julie Bruneau's work include HIV, Drug Use, Sexual Risk (98 papers), Hepatitis C virus research (85 papers) and Opioid Use Disorder Treatment (55 papers). Julie Bruneau is often cited by papers focused on HIV, Drug Use, Sexual Risk (98 papers), Hepatitis C virus research (85 papers) and Opioid Use Disorder Treatment (55 papers). Julie Bruneau collaborates with scholars based in Canada, Australia and United States. Julie Bruneau's co-authors include Naglaa H. Shoukry, Matthew Hickman, Francesco Leri, Louisa Degenhardt, Jane Stewart, Peter Vickerman, Didier Jutras‐Aswad, Jason Grebely, Geng Zang and Élise Roy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Medicine.

In The Last Decade

Julie Bruneau

203 papers receiving 7.9k citations

Hit Papers

High Rates of Forward Tra... 2007 2026 2013 2019 2007 2019 2012 2018 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Bruneau Canada 43 4.7k 2.2k 2.0k 1.9k 1.2k 211 8.1k
Patrizia Carrieri France 46 4.2k 0.9× 1.3k 0.6× 916 0.5× 4.6k 2.5× 109 0.1× 324 8.7k
Giovanni Guaraldi Italy 46 3.1k 0.7× 458 0.2× 812 0.4× 4.0k 2.2× 401 0.3× 407 9.4k
Ruth M. Greenblatt United States 48 3.1k 0.7× 1.1k 0.5× 251 0.1× 3.8k 2.1× 635 0.5× 171 8.7k
Kathryn Anastos United States 60 4.5k 1.0× 1.0k 0.5× 384 0.2× 5.8k 3.1× 803 0.7× 418 12.8k
Lisa P. Jacobson United States 65 4.0k 0.9× 643 0.3× 457 0.2× 6.2k 3.4× 2.0k 1.7× 300 14.7k
Eric C. Seaberg United States 45 3.5k 0.8× 305 0.1× 2.8k 1.4× 1.6k 0.9× 259 0.2× 125 7.3k
Colette Smith United Kingdom 40 2.8k 0.6× 324 0.1× 502 0.3× 3.7k 2.0× 396 0.3× 233 6.9k
Estebán Martínez Spain 47 2.4k 0.5× 475 0.2× 774 0.4× 5.0k 2.7× 267 0.2× 323 8.5k
Ellie E. Schoenbaum United States 42 4.1k 0.9× 1.1k 0.5× 259 0.1× 5.8k 3.1× 397 0.3× 136 9.1k
Phyllis C. Tien United States 51 2.3k 0.5× 349 0.2× 912 0.5× 3.5k 1.9× 315 0.3× 288 8.2k

Countries citing papers authored by Julie Bruneau

Since Specialization
Citations

This map shows the geographic impact of Julie Bruneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Bruneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Bruneau more than expected).

Fields of papers citing papers by Julie Bruneau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Bruneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Bruneau. The network helps show where Julie Bruneau may publish in the future.

Co-authorship network of co-authors of Julie Bruneau

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Bruneau. A scholar is included among the top collaborators of Julie Bruneau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Bruneau. Julie Bruneau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bruneau, Julie, Iuliia Makarenko, Nanor Minoyan, et al.. (2023). HCV treatment initiation in the era of universal direct acting antiviral coverage – Improvements in access and persistent barriers. International Journal of Drug Policy. 113. 103954–103954. 4 indexed citations
3.
Barbieri, Sebastiano, Evan B. Cunningham, Marc van der Valk, et al.. (2023). Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study. Journal of the International AIDS Society. 26(9). e26168–e26168. 3 indexed citations
4.
Pagliuzza, Amélie, Nicolas Chomont, Julie Bruneau, et al.. (2023). DAA-mediated HCV cure reduces HIV DNA levels in HCV/HIV coinfected people. Journal of Virology. 97(12). e0110523–e0110523. 3 indexed citations
5.
Passos‐Castilho, Ana Maria, Donald G. Murphy, Karine Blouin, et al.. (2023). A population‐based study of reported hepatitis C diagnoses from 1998 to 2018 in immigrants and nonimmigrants in Quebec, Canada. Journal of Viral Hepatitis. 30(8). 656–666. 3 indexed citations
6.
Wong, William, Josephine Wong, Karen E. Bremner, et al.. (2023). Impact of direct‐acting antiviral treatment on health utility in patients with chronic hepatitis C in hospital and community settings. Liver International. 43(4). 805–818. 2 indexed citations
8.
Rizkallah, Élie, Paméla Thébault, Stéphanie Lepage, et al.. (2021). Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trial. Neuropsychopharmacology. 46(12). 2101–2111. 10 indexed citations
9.
Jin, Harry, Brandon D. L. Marshall, Louisa Degenhardt, et al.. (2020). Global opioid agonist treatment: a review of clinical practices by country. Addiction. 115(12). 2243–2254. 52 indexed citations
10.
Iversen, Jenny, Handan Wand, Judith I. Tsui, et al.. (2019). Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection. Clinical Infectious Diseases. 70(1). 123–131. 10 indexed citations
11.
Hajarizadeh, Behzad, Evan B. Cunningham, Heather Valerio, et al.. (2019). Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis. Journal of Hepatology. 72(4). 643–657. 114 indexed citations
12.
Høj, Stine Bordier, Brendan Jacka, Nanor Minoyan, Andreea Adelina Artenie, & Julie Bruneau. (2019). Conceptualising access in the direct-acting antiviral era: An integrated framework to inform research and practice in HCV care for people who inject drugs. International Journal of Drug Policy. 72. 11–23. 35 indexed citations
13.
Jacka, Brendan, Élise Roy, Stine Bordier Høj, et al.. (2019). Sexual behaviour as a risk factor for hepatitis C virus infection among people who inject drugs in Montreal, Canada. Journal of Viral Hepatitis. 26(12). 1413–1422. 5 indexed citations
14.
15.
Isitman, Gamze, Colin Kovacs, Marianne Harris, et al.. (2016). Antibody-Dependent Cellular Cytotoxicity Activity of Effector Cells from HIV-Infected Elite and Viral Controllers. AIDS Research and Human Retroviruses. 32(10-11). 1079–1088. 12 indexed citations
16.
Isitman, Gamze, Rujun Song, Sandrina DaFonseca, et al.. (2015). A Higher Frequency of NKG2A + than of NKG2A NK Cells Responds to Autologous HIV-Infected CD4 Cells irrespective of Whether or Not They Coexpress KIR3DL1. Journal of Virology. 89(19). 9909–9919. 33 indexed citations
17.
MacArthur, Georgina J, Silvia Minozzi, Natasha K. Martin, et al.. (2012). Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ. 345(oct03 3). e5945–e5945. 359 indexed citations breakdown →
18.
Bruneau, Julie, et al.. (2010). Socio-economic determinants of the adoption of budded planting materials in rubber smallholdings of the South West region, Cameroon. Scientific Research and Essays. 5(4). 407–411. 4 indexed citations
19.
Jalbert, Emilie, Mohamed‐Rachid Boulassel, Jean‐Pierre Routy, et al.. (2005). Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV-1. AIDS. 19(8). 775–784. 25 indexed citations
20.
Routy, Jean‐Pierre, Philippe Vanhems, Danielle Rouleau, et al.. (2000). Comparison of Clinical Features of Acute HIV-1 Infection in Patients Infected Sexually or Through Injection Drug Use. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(5). 425–432. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026